Literature DB >> 10448466

Modern management of eclampsia.

O Salha1, J J Walker.   

Abstract

Eclampsia, the occurrence of a seizure in association with pre-eclampsia, remains an important cause of maternal mortality and morbidity. Despite being recognised since antiquity, consistent management practices are still lacking. Given that the aim of good care is to prevent seizures, it is disappointing that in the majority of cases the first eclamptic convulsion occurs after admission to hospital. This indicates that either the women who are likely to have a convulsion were not identified accurately, or the treatment given was ineffective. The answer to poor management of eclampsia lies in better education and training of all obstetricians, anaesthetists, midwives, and general practitioners in the diagnosis and treatment of severe pre-eclampsia and eclampsia. Protocols for the management of fluid balance, antihypertensive and anticonvulsant therapies should be available and reviewed regularly. The universal adoption of such guidelines in all obstetric units would substantially reduce elements of substandard care which have repeatedly been identified in the triennial reports of the confidential enquiries into maternal deaths in the UK.

Entities:  

Mesh:

Year:  1999        PMID: 10448466      PMCID: PMC1741124          DOI: 10.1136/pgmj.75.880.78

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  44 in total

1.  Are prophylactic anticonvulsants required in severe pre-eclampsia?

Authors:  S Chua; C W Redman
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

Review 2.  Hypertensive drugs in pregnancy. Antihypertension therapy in pregnancy, preeclampsia, and eclampsia.

Authors:  J J Walker
Journal:  Clin Perinatol       Date:  1991-12       Impact factor: 3.430

3.  Complications related to the pressor response to endotracheal intubation.

Authors:  E J Fox; G S Sklar; C H Hill; R Villanueva; B D King
Journal:  Anesthesiology       Date:  1977-12       Impact factor: 7.892

4.  Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases.

Authors:  B M Sibai
Journal:  Am J Obstet Gynecol       Date:  1990-09       Impact factor: 8.661

5.  Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.

Authors:  A Garden; D A Davey; J Dommisse
Journal:  Clin Exp Hypertens B       Date:  1982

6.  Management of severe pre-eclampsia and eclampsia by UK consultants.

Authors:  J D Hutton; D K James; G M Stirrat; K A Douglas; C W Redman
Journal:  Br J Obstet Gynaecol       Date:  1992-07

7.  The management of severe pre-eclampsia and eclampsia.

Authors:  B M Hibbard; M Rosen
Journal:  Br J Anaesth       Date:  1977-01       Impact factor: 9.166

8.  A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy.

Authors:  J Moodley; E Gouws
Journal:  Br J Obstet Gynaecol       Date:  1992-09

9.  Eclampsia in the United Kingdom.

Authors:  K A Douglas; C W Redman
Journal:  BMJ       Date:  1994-11-26

10.  Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension.

Authors:  M A Brown; V C Zammit; S A Lowe
Journal:  Clin Sci (Lond)       Date:  1989-12       Impact factor: 6.124

View more
  1 in total

1.  Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings.

Authors:  Ricardo Perez-Cuevas; William Fraser; Hortensia Reyes; Daniel Reinharz; Ashi Daftari; Cristina S Heinz; James M Roberts
Journal:  BMC Pregnancy Childbirth       Date:  2003-10-03       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.